Macular Degeneration Treatment in Moradabad — Preserving Central Vision with Dr. Deeksha Singh at Jigyasa Hospital

As people age, changes can occur in the macula — the small but critically important central part of the retina responsible for sharp, detailed vision used in reading, recognising faces, and driving. When this area is affected by age-related macular degeneration (AMD), central vision gradually becomes blurred or distorted, even though side (peripheral) vision usually remains intact. For older adults in Moradabad and the surrounding region, this can be an unsettling and often misunderstood diagnosis.

At Jigyasa Hospital, Dr. Deeksha Singh provides comprehensive evaluation and treatment for macular degeneration, with an emphasis on early detection, accurate staging, and treatment approaches tailored to each patient's specific type and stage of disease.

What Is Macular Degeneration?

The macula is a small, specialised area near the centre of the retina, responsible for the fine, detailed central vision we rely on for tasks like reading, recognising faces, and threading a needle. Age-related macular degeneration occurs when this area gradually deteriorates, most commonly in people over the age of 50, though it can occasionally occur earlier.

AMD affects central vision while typically sparing peripheral vision, which means patients rarely go completely blind from this condition. However, the loss of clear central vision can significantly affect a person's ability to read, drive, recognise faces, and carry out many everyday tasks independently, making early detection and management important for preserving quality of life.

There are two main types of age-related macular degeneration:

Dry (Atrophic) AMD

This is the more common form, accounting for the majority of cases. It develops slowly as the light-sensitive cells of the macula thin out over time, often associated with the build-up of small yellow deposits called drusen beneath the retina. Dry AMD typically progresses gradually over years, though a subset of patients may eventually develop the wet form.

Wet (Neovascular) AMD

This form is less common but more aggressive. It occurs when abnormal, fragile new blood vessels grow beneath the retina and leak fluid or blood, causing rapid and often significant damage to central vision if not treated promptly. Wet AMD is responsible for the majority of severe vision loss associated with macular degeneration, which is why prompt diagnosis and treatment are especially critical for this form.

Who Is at Risk of Macular Degeneration?

While age is the single biggest risk factor, several other factors influence a person's risk of developing AMD:

Key Risk Factors

Recognising the Symptoms of Macular Degeneration

Macular degeneration often develops gradually, and early symptoms can be subtle enough to be mistaken for normal age-related vision changes. Common symptoms include:

Common Symptoms

Wet AMD, in particular, can cause a sudden, noticeable change in vision, and any rapid change — especially new distortion or a sudden blurred or blank patch in central vision — should be treated as urgent and evaluated as soon as possible, since prompt treatment can make a significant difference in preserving vision.

Why Early Detection Matters

Macular degeneration cannot currently be cured, but its progression can often be slowed, and in the case of wet AMD, active treatment can help stabilise or even improve vision if started promptly.

The challenge is that by the time symptoms become obvious to the patient, some degree of damage has usually already occurred. This is why:

• • Routine eye examinations become increasingly important after age 50, even without symptoms
• • Patients with a family history of AMD should mention this so their risk can be factored into screening recommendations
• • Any new distortion, blurring, or blank spots in central vision should prompt an urgent evaluation rather than a wait-and-see approach
• • Patients already diagnosed with dry AMD should be aware of the signs of progression to wet AMD, so any change can be caught and treated quickly

How Macular Degeneration Is Diagnosed at Jigyasa Hospital

A comprehensive evaluation is essential not only to confirm the diagnosis but to determine the specific type and stage of AMD, which directly guides the treatment approach. The evaluation typically includes:

1. Detailed History

Including duration of symptoms, family history, smoking history, and any cardiovascular risk factors.

2. Visual Acuity Testing

To assess the current level of central vision.

3. Amsler Grid Testing

A simple grid pattern used to detect distortion or missing areas in central vision, which can also be used by patients at home to monitor for changes between visits.

4. Dilated Fundus Examination

A detailed view of the macula and retina using pupil-dilating drops.

5. Optical Coherence Tomography (OCT)

A non-invasive imaging test that provides detailed cross-sectional images of the retina, allowing precise assessment of macular thickness, fluid, and structural changes. OCT plays a central role in both diagnosing AMD and monitoring response to treatment.

6. Fundus Photography

Detailed retinal photographs used to document the current state of the macula and track changes over time.

7. Fluorescein or OCT Angiography, Where Indicated

Specialised imaging that highlights abnormal blood vessels, particularly useful in confirming and characterising wet AMD.

This detailed work-up allows the treating doctor to distinguish between dry and wet AMD, assess severity, and determine the most appropriate treatment plan.

Treatment Options for Macular Degeneration

Treatment for AMD is tailored to the type and stage of the disease, since dry and wet AMD are managed quite differently.

Management of Dry AMD

Nutritional support: For patients with intermediate or advanced dry AMD, specific formulations of vitamins and antioxidants — often referred to as AREDS-type supplements — have been shown in research to help reduce the risk of progression in certain patients. Whether these are appropriate is assessed individually, based on the stage and characteristics of the disease.

• • Lifestyle modification: Since smoking, diet, and cardiovascular health all influence AMD risk and progression, patients are often guided toward smoking cessation, a diet rich in leafy greens and omega-3 fatty acids, and better control of blood pressure and cholesterol.
• • Regular monitoring: Because dry AMD can sometimes progress or convert to wet AMD, regular follow-up examinations, including OCT imaging, are recommended to catch any change early. Patients are often taught to use an Amsler grid at home to self-monitor for new distortion between visits.
• • Low vision support: For patients with more advanced vision loss from dry AMD, low vision aids — such as magnifiers, adapted lighting, and other assistive tools — can help maximise the use of remaining vision for daily tasks.

Treatment of Wet AMD

Anti-VEGF injections: This is the primary treatment for wet AMD. These medications are injected directly into the eye and work by blocking the abnormal blood vessel growth and leakage responsible for wet AMD's rapid vision loss. Many patients experience stabilisation of vision, and a significant proportion see meaningful improvement, particularly when treatment begins promptly. Treatment typically involves an initial series of injections followed by an individualised maintenance schedule based on how the eye responds, monitored closely through follow-up OCT scans.

• • Ongoing monitoring and retreatment: Wet AMD generally requires long-term management, since the underlying tendency toward abnormal vessel growth can persist. Regular follow-up visits allow the treatment schedule to be adjusted based on the eye's response over time.
• • Laser treatment, in select cases: While largely superseded by anti-VEGF therapy for most patients, certain specific presentations of wet AMD may still be considered for laser treatment as part of an individualised plan.

Living Well with Macular Degeneration

A diagnosis of AMD can understandably be worrying, but it's important to understand that AMD does not cause total blindness — peripheral vision is preserved, which means most patients retain the ability to navigate their surroundings independently even if central vision, needed for tasks like reading and recognising fine detail, is affected.

With appropriate treatment, regular monitoring, and support, many patients continue to lead active, independent lives. Helpful strategies alongside medical treatment include:

Helpful Strategies

Why Choose Jigyasa Hospital for Macular Degeneration Care in Moradabad

Patients across Moradabad, Rampur, Amroha, and Sambhal trust Jigyasa Hospital for macular degeneration care because of its combination of detailed diagnostic capability and individualised, ongoing management:

What Sets Jigyasa Hospital Apart

Serving Moradabad and the Surrounding Region

Jigyasa Hospital's accessible location on Rampur Road, near Miglani Cinema, brings quality macular degeneration care within reach for families across Moradabad and the wider region, including Rampur, Sambhal, Amroha, and nearby districts. This accessibility means families don't need to travel long distances to access thorough, specialist retina care.

Frequently Asked Questions